Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Clinical trial NCT02633046 · COMPLETED

Trial details

NCT number: NCT02633046
Sponsor: Mallinckrodt ARD LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Idiopathic Focal Segmental Glomerulosclerosis

Start date: 2016-10-10
Primary completion: 2020-08-27
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.